Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Atai Life Sciences reports Q3 results, highlighting FDA clearance for DMT film, upcoming MDMA trials, and a strong cash position. read more ​ ​Atai Life Sciences reports Q3 results, highlighting FDA clearance for DMT film, upcoming MDMA trials, and a strong cash position. read moreÂ